International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs

被引:1
|
作者
Caruso, C. [1 ]
Canonica, G. W. [2 ]
Patel, M. [3 ]
Smith, A. [3 ]
Liu, M. C. [4 ]
Alfonso-Cristancho, R. [5 ]
Price, R. G. [6 ]
Jakes, R. W. [7 ]
Demetriou, L. [8 ]
Valero, A. [9 ]
Pilette, C. [10 ]
Howarth, P. [11 ]
机构
[1] Fdn Policlin Gemelli, IRCCS, UOSD DH Gastroenterol, Rome, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Univ Hosp Wishaw, Dept Resp Med, Wishaw, Scotland
[4] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, Biostat, Stevenage, Herts, England
[7] GSK, Epidemiol, GSK House, Brentford, England
[8] GSK, Value Evidence & Outcomes, Stevenage, Herts, England
[9] Univ Barcelona, IDIBAPS, CIBER Enfermedades Respiratorias CIBERES, Hosp Clin Barcelona,Secc Alergol,Serv Neumol & Al, Barcelona, Spain
[10] CIBER Enfermedades Resp CIBERES, IDIBAPS, Barcelona, Spain
[11] Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
关键词
D O I
10.1183/13993003.congress-2022.4589
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
4589
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study
    Schleich, F.
    Lougheed, M.
    Matucci, A.
    Hermosa, J. Rodriguez
    Pfeffer, P.
    Verghis, R. M.
    Jakes, R. W.
    Alfonso-Cristancho, R.
    Liu, M. C.
    Welte, T.
    Bals, R.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [32] REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS
    Bagnasco, Diego
    Hill, David G.
    Welte, Tobias
    Chaudhuri, Rekha
    Price, Robert
    Howarth, Peter
    [J]. CHEST, 2023, 164 (04) : 75A - 76A
  • [33] THE SUSTAINED OCS-SPARING EFFECT OF MEPOLIZUMAB: RESULTS FROM THE REAL-WORLD REALITI-A STUDY AT 2 YEARS
    Pollard, S.
    Offenberger, J.
    Lee, F.
    Liu, M.
    Alfonso-Cristancho, R.
    Price, R.
    Howarth, P.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S43 - S43
  • [34] Influence of Baseline Total IgE and History of Previous Omalizumab Use on the Impact of Mepolizumab in Reducing Rate of Severe Asthma Exacerbations: Results From the Real-World REALITI-A Study
    Lee, Jason
    Pollard, Stephen
    Liu, Mark
    Schleich, Florence
    Pelaia, Girolamo
    Almonacid, Carlos
    Heaney, Liam
    Chaudhuri, Rekha
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB191 - AB191
  • [35] EFFECTIVENESS AND SAFETY OF MEPOLIZUMAB IN REAL-WORLD CLINICAL PRACTICE: UK PATIENT OUTCOMES FROM THE REALITI-A STUDY
    Kerr, W. A. F.
    Harrison, T. W.
    Loveday, K.
    Joksaite, S.
    Kwon, N.
    [J]. THORAX, 2019, 74 : A140 - A140
  • [36] The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study
    Liu, Mark
    Schleich, Florence
    Lee, Jason
    Pelaia, Girolamo
    Sanchez, Carlos Almonacid
    Heaney, Liam
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB147 - AB147
  • [37] Real-World mepolizumab outcomes in severe asthma; REALITI- A post hoc analysis by exacerbation history
    Bagnasco, D.
    Lougheed, D.
    Subramanian, V
    Clifton, I
    Price, R.
    Howarth, P.
    Skowasch, D.
    [J]. PNEUMOLOGIE, 2024, 78 : S10 - S11
  • [38] A STUDY OF INTACT CANAL WALL TECHNIQUE IN PAEDIATRIC CHOLESTEATOMA PATIENTS FOR 2YRS IN GGH, KURNOOL
    Ahmed, Mohammed Naveed
    Kumar, M. Mahendra
    Prasad, A. Sesha
    Ahmed, S. Muneeruddin
    Kumar, M. Praveen
    Rao, C. V.
    Nagaraju, Aghiri
    Prasad, B. Durga
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (34): : 9057 - 9067
  • [39] Case study: A Combination of Mepolizumab and Omaluzimab injections for severe asthma
    Dedaj, Rejmon
    Unsel, Lindie
    [J]. JOURNAL OF ASTHMA, 2019, 56 (05) : 473 - 474
  • [40] Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study
    Ortega, Hector
    Liu, Mark
    Pavord, Ian
    Brusselle, Guy
    FitzGerald, J. Mark
    Chetta, Alfredo
    Katz, Lynn
    Keene, Oliver
    Yancey, Steven
    Chanez, Pascal
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44